Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 7:16:1573963.
doi: 10.3389/fendo.2025.1573963. eCollection 2025.

Association of circulating 25-hydroxyvitamin D with time in range and insulin secretion in type 2 diabetes

Wenwen Jiang #  1 , Ling Li #  2 , Wei Wang #  3 , Yue Liang  3 , Xiaoyong Bai  4 , Yixin Xu  4 , Qingyu Guo  4 , Lichao Ge  1 , Jingjing Liang  4 , Bin Lu  3 , Jiaqing Shao  1   3   5
Affiliations

Association of circulating 25-hydroxyvitamin D with time in range and insulin secretion in type 2 diabetes

Wenwen Jiang et al. Front Endocrinol (Lausanne). .

Abstract

Background: To explore the association of circulating 25-hydroxyvitamin D [25(OH)D] with time in range and insulin secretion in type 2 diabetes.

Methods: 911 patients diagnosed with type 2 diabetes mellitus (T2DM) were included, and they underwent 3-day continuous glucose monitoring (CGM) and serum 25(OH)D measurements. The subjects were categorized into three groups based on the tertiles of their serum 25(OH)D levels: G1 (25(OH)D ≤ 21.22 ng/mL), G2 (21.22 ng/mL ≤ 25(OH)D < 26.43 ng/mL), and G3 (25(OH)D ≥ 26.43 ng/mL). TIR and glycemic variability (GV) parameters were evaluated with CGM. Insulin resistance was evaluated via the homeostatic model assessment of insulin resistance (HOMA-IR). The pancreatic β-cell function was determined using the homeostasis model assessment of β-cell function (HOMA-β). Among the 911 enrolled subjects, 582 individuals underwent a 100g standardized steamed bread meal test to comprehensively evaluate the pancreatic β-cell secretory function.

Results: A higher TIR and time in tight range (TITR) were observed among individuals in the upper tertile for 25(OH)D, surpassing those in the middle and lower tertiles. The results of correlation analysis revealed that serum 25(OH)D levels were significantly positively correlated with TIR and TITR. Conversely, serum 25(OH)D levels were negatively associated with time above range, GV parameters, hemoglobin A1c (HbA1c), and HOMA-IR. However, no significant association was observed between serum 25(OH)D levels and HOMA-β. Additionally, the correlation between 25(OH)D and TIR (r=0.217, P<0.001) was slightly stronger than that between 25(OH)D and HbA1c (r=-0.130, P<0.001). Multiple stepwise linear regression analysis indicated that serum 25(OH)D levels were an independent influencing factor for TIR. Among individuals who underwent the steamed bread meal test, serum 25(OH)D exhibited a positive correlation with indicators of early-phase and overall pancreatic β-cell secretion capacity.

Conclusions: This study demonstrated that in patients with T2DM, 25(OH)D levels exhibited positive correlations with TIR and glucose-stimulated insulin secretion parameters, while showing negative correlations with GV parameters. Lower serum 25(OH)D levels may adversely impact glucose homeostasis and pancreatic β-cell secretory function in T2DM patients.

Keywords: 25-hydroxyvitamin D; homeostatic model assessment of insulin resistance; homeostatic model assessment of β cell function; time in range; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the participants included in the present study.
Figure 2
Figure 2
The correlation between 25(OH)D and TIR/HbA1c. (a) The relationship between serum 25(OH)D and TIR (n = 911, 2-tailed Spearmen correlation). (b) The relationship between serum 25(OH)D and HbA1c (n = 911, 2-tailed Spearmen correlation).
See this image and copyright information in PMC

References

    1. Saponaro F, Saba A, Zucchi R. An update on vitamin D metabolism. Int J Mol Sci. (2020) 21:6573. doi: 10.3390/ijms21186573 - DOI - PMC - PubMed
    1. Pepaj M, Bredahl MK, Gjerlaugsen N, Bornstedt ME, Thorsby PM. Discovery of novel vitamin D-regulated proteins in ins-1 cells: A proteomic approach. Diabetes/Metabolism Res Rev. (2015) 31:481–91. doi: 10.1002/dmrr.2629 - DOI - PubMed
    1. Mendes AKB, Sulis PM, Cavalari FC, Padilla DPR, Aragón M, Gaspar JM, et al. 1α,25-(OH)2 vitamin D3 prevents insulin resistance and regulates coordinated exocytosis and insulin secretion. J Nutr Biochem. (2022) 99:108864. doi: 10.1016/j.jnutbio.2021.108864 - DOI - PubMed
    1. Abed MN, Alassaf FA, Qazzaz ME. Exploring the interplay between vitamin D, insulin resistance, obesity and skeletal health. J Bone Metab. (2024) 31:75–89. doi: 10.11005/jbm.2024.31.2.75 - DOI - PMC - PubMed
    1. Yang L. Decreased serum levels of 25-OH vitamin D and vitamin K in patients with type 2 diabetes mellitus. Front Endocrinol. (2024) 15:1412228. doi: 10.3389/fendo.2024.1412228 - DOI - PMC - PubMed

LinkOut - more resources